Abstract:Antibiotic resistance has become a serious threat to public health, thus novel antibiotics are urgently needed to combat drug-resistant bacteria including MRSA (methicillin-resistant ). The 1,4-dicarbonylthiosemicarbazide is an interesting chemotype that could exhibit antibacterial activity. However, the currently available compounds are not as potent as clinical antibiotics. Herein, we adopted the computer-aided drug design strategy, substructure search, to retrieve antibacterial 1,4-dicarbonylthiosemicarbazide derivatives, and identified compound (Specs ID: AG-690/15432331) from the Specs chemical library that exhibited moderate activity (minimum inhibitory concentration (MIC): 6.25 µg/mL) against (ATCC 29213). Based on that compound, we further designed and synthesized 45 derivatives, and evaluated their antibacterial activity. Eight derivatives were more potent than or equivalent to vancomycin (MIC: 1.56 µg/mL). We compared the three most potent ones for their cytotoxicity to HepG2 and HUVEC cells and selected compound as our lead compound for comprehensive biological evaluation. As a result, compound exhibited a bacteriostatic mode, and was active against a panel of gram-positive bacteria strains, metabolically stable, and effective to protect the mice from MRSA infection. More importantly, we applied 2D similarity calculation and reverse docking to predict potential targets of compound . Through experimental validation and molecular dynamics simulation, we were able to confirm that compound inhibited DNA gyrase (IC : 1.81 µM) and DNA supercoiling, potentially by binding to the ATPase domain, where ASP81, GLU58 and GLN91 formed key hydrogen bonds. Taken together, we have discovered a new class of DNA gyrase inhibitors represented by compound for the treatment of MRSA infection, through the design, synthesis, and biological evaluation of novel 1,4-dicarbonylthiosemicarbazides.

Design, synthesis, and biological evaluation of novel carbazole aminothiazoles as potential DNA-targeting antimicrobial agents

Multi-Targeting Exploration of New 2-Aminothiazolyl Quinolones: Synthesis, Antimicrobial Evaluation, Interaction with Dna, Combination with Topoisomerase Iv and Penetrability into Cells

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Novel Potentially Antibacterial Naphthalimide-Derived Metronidazoles: Design, Synthesis, Biological Evaluation and Supramolecular Interactions with DNA, Human Serum Albumin and Topoisomerase II

Unique Aminothiazolyl Coumarins As Potential DNA and Membrane Disruptors Towards Enterococcus Faecalis

Design, Synthesis and Biological Evaluation of Amino Organophosphorus Imidazoles As a New Type of Potential Antimicrobial Agents

Novel Naphthalimide Aminothiazoles As Potential Multitargeting Antimicrobial Agents

Design, synthesis and biological evaluation of berberine-benzimidazole hybrids as new type of potentially DNA-targeting antimicrobial agents.

Design, Synthesis and Antimicrobial Evaluation of Novel Benzimidazole-Incorporated Sulfonamide Analogues

Design, synthesis, and antibacterial evaluation of novel azolylthioether quinolones as MRSA DNA intercalators

Design, Synthesis, and Biological Evaluation of Novel Benzimidazole Derivatives and Their Interaction with Calf Thymus DNA and Synergistic Effects with Clinical Drugs

Synthesis and Bioactive Evaluations of Novel Benzotriazole Compounds As Potential Antimicrobial Agents and the Interaction with Calf Thymus DNA

Design, Synthesis, and Biological Evaluation of Novel Sulfonamide 1,2,4-Triazoles and Their Interaction with Calf Thymus DNA

Design, Synthesis, and Antimicrobial Evaluation of Novel Quinolone Imidazoles and Interactions with MRSA DNA

Design and Synthesis of Quinazolinone Imidazoles and Their Antibacterial and DNA-targeting Investigation

Discovery of novel 1,4-dicarbonylthiosemicarbazides as DNA gyrase inhibitors for the treatment of MRSA infection

Novel Carbazole-Triazole Conjugates As DNA-targeting Membrane Active Potentiators Against Clinical Isolated Fungi.

A New Exploration Towards Aminothiazolquinolone Oximes As Potentially Multi-Targeting Antibacterial Agents: Design, Synthesis and Evaluation Acting on Microbes, DNA, HSA and Topoisomerase IV

Design, Synthesis and Evaluation of Carbazole Derivatives As Potential Antimicrobial Agents

Novel Organophosphorus Aminopyrimidines As Unique Structural DNA-targeting Membrane Active Inhibitors Towards Drug-Resistant Methicillin-Resistant Staphylococcus Aureus

Synthesis, and Antibacterial Activity of Novel 4,5-Dihydro-1h-pyrazole Derivatives As DNA Gyrase Inhibitors.